Related references
Note: Only part of the references are listed.Reconstruction after proximal gastrectomy for gastric cancer in the upper third of the stomach: a review of the literature published from 2000 to 2014
Masaki Nakamura et al.
SURGERY TODAY (2016)
Current status of robotic gastrectomy for gastric cancer
Kazutaka Obama et al.
SURGERY TODAY (2016)
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
Jin Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
Se Hoon Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S. Fuchs et al.
LANCET (2014)
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
Sung Hoon Noh et al.
LANCET ONCOLOGY (2014)
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke et al.
LANCET ONCOLOGY (2014)
Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy
Takaki Yoshikawa et al.
SURGERY TODAY (2014)
A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review
Roberta Cardoso et al.
GASTRIC CANCER (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery
Toshiro Okuyama et al.
SURGERY TODAY (2012)
Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
D. Takahari et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Surgical Resection Following Combination Chemotherapy with Oral S-1 and Biweekly Docetaxel in a Patient with Advanced Gastric Cancer and a Prior Coronary Artery Bypass Graft with the Right Gastroepiploic Artery: Report of a Case
Nobuhide Kubo et al.
SURGERY TODAY (2011)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Okines et al.
ANNALS OF ONCOLOGY (2010)
Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of Gastric Adenocarcinoma in Comparison With the Sixth Classification
Hye Seong Ahn et al.
CANCER (2010)
A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703)
Yasuhiro Kodera et al.
GASTRIC CANCER (2010)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
Christoph Schuhmacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Prognostic Factors for Local Control After Breast Conservation: Does Margin Status Still Matter?
Shannon MacDonald et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer
Mitsuru Sasako et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Principles of surgical treatment for curable gastric cancer
M Sasako
JOURNAL OF CLINICAL ONCOLOGY (2003)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
